Clinical Trials on Malignant Pancreatic Somatostatinoma

Total 10647 results

University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Recruiting

Geriatric Evaluation and Management With Survivorship Health Education (GEMS) for Older Survivors of Cancer

Malignant Solid Neoplasm

United States
Pennington Biomedical Research Center

Recruiting

A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer (Small Steps)

Neoplasm Malignant

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm

United States
Akesobio Australia Pty Ltd

Recruiting

A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Neoplasms Malignant

Australia
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Malignant Solid Neoplasm

United States, Puerto Rico
University of Southern California
National Cancer Institute (NCI)

Recruiting

Movement and Fitness Trackers in Determining Performance Status

Malignant Neoplasm

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Malignant Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment

Malignant Neoplasm

United States
Fred Hutchinson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)

Suspended

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Non-Malignant Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

Malignant Neoplasm

United States
National Cancer Institute (NCI)

Active, not recruiting

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Malignant Solid Neoplasm

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Reproductive Health Program in Patients With Cancer (EROS)

Malignant Neoplasm

United States
Capital Medical University

Completed

Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy

Malignant Tumor

China
Capital Medical University

Completed

Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy

Malignant Tumor

China
Jonsson Comprehensive Cancer Center

Active, not recruiting

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Malignant Neoplasm

United States
Durham University
County Durham and Darlington NHS Foundation Trust

Suspended

Terahertz Metamaterials for Tumour Marker Concentration Identification

Malignant Tumour

United Kingdom
NatureWise Biotech & Medicals Corporation

Completed

A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer

Malignant Neoplasm

Taiwan
Sanofi

Completed

Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid Tumors

Neoplasm Malignant

Japan
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care

Malignant Neoplasm

United States
Jonsson Comprehensive Cancer Center

Terminated

Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy

Malignant Neoplasm

United States
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors

Malignant Tumors

Japan
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Completed

Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy

Malignant Neoplasm

United States
Asclepius Technology Company Group (Suzhou) Co....

Unknown

Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor

Malignant Tumor

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer

Malignant Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Communication Effectiveness in Cancer Treatment

Malignant Neoplasm

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Evidence-Based Tobacco Cessation Strategies in Patients With Cancer

Malignant Neoplasm

United States
Sanofi

Completed

First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor

Neoplasm Malignant

United States, Spain, France
Emory University

Completed

Potential Use of Indocyanine Green as a Fluorescent Agent for Definition of Surgical Margins in Cancer

Malignant Neoplasm

United States
InnoPharmax Inc.

Completed

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

Malignant Tumors

Taiwan, United States
Sanofi

Completed

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Neoplasm Malignant

United States
University Hospital, Bordeaux

Completed

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells (GRAPA)

Malignant Haematological Disease

France
Sanofi

Completed

Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors

Neoplasms, Malignant

France, United Kingdom, Italy
Sanofi

Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Neoplasms, Malignant

Japan
Sanofi

Terminated

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Neoplasms, Malignant

United States
Indiana University

Completed

A Prospective Study of Thin Prep Versus Papanicolau in Suspected Malignant Lesions During Endoscopic Ultrasound (EUS)

Suspected Malignant Lesions

United States
Seoul National University Hospital

Unknown

Cancer Genome Analysis

Malignant Tumor

Korea, Republic of
Pfizer

Completed

A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies

Neoplasm, Malignant

Japan
Institut Claudius Regaud
Merck Sharp & Dohme LLC

Terminated

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Malignant Solid Tumour

France
Ohio State University
AbbVie

Active, not recruiting

Post Acute Pancreatitis Pancreatic Exocrine Insufficiency (PAPPEI)

Acute Pancreatitis

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

An Investigational Scan (68Ga-FAPI-46 PET/CT) for the Imaging of Cancer-Associated Fibroblasts in Patients With Localized Pancreatic Ductal Adenocarcinoma

Stage 0 Pancreatic Cancer AJCC v8 | Stage I Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Resectable Pancreatic Ductal Adenocarcinoma | Localized Pancreatic Adenocarcinoma

United States
Vanderbilt University Medical Center

Terminated

Lumen Apposing Metal Stents vs Lumen Apposing Metal Stent Plus Double Pigtail Stent for Endoscopic Drainage (Axios)

Pancreatic Pseudocyst

United States
University of Oklahoma

Terminated

Registry and Fluid Banking of Pancreatic Cystic Lesions

Pancreatic Cysts

United States
Yiqi Du

Unknown

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts

Pancreatic Pseudocyst
Immuneering Corporation

Recruiting

A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors

Pancreatic Adenocarcinoma | Advanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC) | Malignant Melanoma (Cutaneous)

United States
Aveni Foundation

Available

BLESSED: Expanded Access for DeltaRex-G for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Sarcoma | Soft Tissue Sarcoma | Pancreatic Cancer | Osteosarcoma | Chondrosarcoma | Chordoma | Carcinoma of Breast | MPNST (Malignant Peripheral Nerve Sheath Tumor)

United States
Bayer

Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)

United States, Sweden, Netherlands, United Kingdom, Finland
Thomas Jefferson University

Recruiting

A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage 0 Pancreatic Cancer AJCC v8 | Stage I Pancreatic Cancer AJCC v8 | Stage IA Pancreatic Cancer AJCC v8 | Stage IB Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Resectable Pancreatic Ductal Adenocarcinoma

United States
National Cancer Institute (NCI)

Terminated

Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Metastatic Pancreatic Cancer | Histologically or Cytologically Confirmed Pancreatic Cancer | Unresectable or Borderline Resectable Pancreatic Cancer

United States
Massimo Raimondo, M.D.
Digestive Care, Inc.

Terminated

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer | Pancreatic Insufficiency | Pancreatic Enzyme Abnormality

United States
Seattle Cancer Treatment and Wellness Center

Unknown

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Stage III Pancreatic Cancer | Stage IVA Pancreatic Cancer | Stage IVB Pancreatic Cancer | Adenocarincoma of Pancreas

United States

Clinical Trials on Malignant Pancreatic Somatostatinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations